Eton Pharmaceuticals Files 8-K for Financials and Exhibits
Ticker: ETON · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1710340
| Field | Detail |
|---|---|
| Company | Eton Pharmaceuticals, Inc. (ETON) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, exhibits
TL;DR
Eton Pharma filed an 8-K for financial updates, nothing major to see here.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on April 1, 2025, reporting on events that occurred on March 31, 2025. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.
Why It Matters
This filing indicates Eton Pharmaceuticals is providing updated financial information and exhibits to the SEC, which is standard practice for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any new risks or significant events.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- 0001710340 (company) — Central Index Key
- 37-1858472 (company) — I.R.S. Employer Identification Number
- 001-38738 (company) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on 'Other Events' and to provide 'Financial Statements and Exhibits' as of March 31, 2025.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on April 1, 2025.
What is Eton Pharmaceuticals, Inc.'s state of incorporation?
Eton Pharmaceuticals, Inc. is incorporated in Delaware.
What is Eton Pharmaceuticals, Inc.'s principal executive office address?
The principal executive offices of Eton Pharmaceuticals, Inc. are located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7208.
Does this filing report any specific material events or changes?
Based on the provided text, this filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' and does not explicitly detail any specific material events or changes beyond the standard reporting of financial information.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).